List of largest biotechnology & pharmaceutical companies

The following is a list of the top 25 independent biotechnology companies listed on a stock exchange (as indicated) ranked by market capitalization. Note that it does not include biotechnology companies that are now owned by, or part of, larger pharmaceutical groups.

Rankings

Rank[N 1] Company Largest Market Cap (USD billions) Market Cap in Q2 2017 (USD billions) Market Cap in 2016 (USD billions)[1][2] Market Cap in 2015 (USD billions)[3] Market Cap in 2014 (USD billions)[4] Market Cap in 2013 (USD billions)
1 SteadyUnited States Johnson & Johnson[P]
NYSE: JNJ
367.5 (June 2017) 356.1 Increase 314.1 284.2 277.8 258.3
2 SteadySwitzerland Roche[P]
OTCQX: RHHBY
263.6 (Feb 2014) 216.7 Decrease 192.1 234.7 258.5 240.3
3 SteadyUnited States Pfizer[P]
NYSE: PFE
310.5 (Jul 2000) 200.5 Decrease 196.3 199.3 205.4 196.0
4 SteadySwitzerland Novartis[P]
NYSE: NVS
275.2 (Jul 2015) 197.5 Increase 170.5 206.1 229.8 195.0
5 SteadyUnited States Merck & Co.[P]
NYSE: MRK
182.8 (Mar 2017) 175.3 Increase 164.3 147.6 166.9 146.5
6 SteadyUnited States AmgenB
NASDAQ: AMGN
134.5 (Mar 2017) 126.7 Increase 108.9 122.5 93.1 78.7
7 SteadyFrance Sanofi[P]
NYSE: SNY
151.3 (Sep 2014) 123.8 Increase 101.8 111.8 138.1 142.0
8 SteadyUnited States AbbVie[P]
NYSE: ABBV
117.9 Jul 2015 115.4 Increase 100.2 96.8 104.1 83.8
9 Increase9Denmark Novo Nordisk[P]
NYSE: NVO
159.6 (Aug 2015) 109.4 Increase 92.6 153.9 125.4 19.6
10 Increase1Germany BayerB
FWB: BAYN
129.0 (Mar 2015) 107.4 Increase 85.3 103.2 113.2 117.4
11 Decrease2United Kingdom GlaxoSmithKline[P]
NYSE: GSK
174.9 (May 2006) 106.0 Increase 93.3 97.6 128.9 129.6
12 Decrease2United States CelgeneB
NASDAQ: CELG
110.0 Jul 2015 101.4 Increase 91.4 94.1 89.5 69.2
13 SteadyUnited States Gilead SciencesB
NASDAQ: GILD
179.6 (Jun 2013) 92.5 Increase 96.6 145.8 109.0 78.4
14 Steady United States Bristol-Myers Squibb[P]
NASDAQ: BMY
128.3 (Jul 2016) 91.8 Increase 98.2 114.8 97.6 87.2
15 Decrease3United States Eli Lilly & Co[P]
NYSE: LLY
122.6 (Aug 2000) 90.8 Decrease 80.9 93.4 76.6 57.0
16 SteadyUnited Kingdom AstraZeneca[P]
NYSE: AZN
102.9 (Oct 2006) 86.3 Increase 68.8 85.8 88.9 74.6
17 SteadyUnited States Abbott Laboratories[P]
NYSE: ABT
85.5 (June 2017) 84.4 Increase 56.4 67.0 67.9 59.3
18 Decrease3Republic of Ireland Allergan[P]
NYSE: AGN
133.5 (Jul 2015) 81.6 Increase 72.7 123.3 68.5 29.3
19 SteadyUnited States Biogen[P]
NASDAQ: BIIB
111.7 (Mar 2015) 57.6 Decrease 61.6 68.3 79.7 66.1
20 Increase2United States Regeneron Pharmaceuticals Inc[P]
NASDAQ: REGN
61.4 (Aug 2015) 52.2 Increase 39.3 56.5 42.0 27.4
21 SteadyUnited States Stryker Corporation[P]
NYSE: SYK
54.1 (June 2017) 51.9 Increase 45.1 34.7 35.7 28.4
22 Decrease2United States Shire Pharmaceuticals[P]
NASDAQ: SHPG
62.0 (Sep 2014) 50.0 Decrease 50.1 41.0 42.4 28.1
23 SteadyIsrael Teva Pharmaceutical[P]
NYSE: TEVA
60.4 (Jul 2015) 33.8 Increase 37.5 55.9 49.0 37.8
24 SteadyUnited States Vertex Pharmaceuticals[P]
NASDAQ: VRTX
34.6 (Aug 2015) 32.1 Increase 18.3 31.0 28.7 17.4
25 SteadyUnited States Zoetis[P]
NASDAQ: ALXN
31.2 (June 2017) 30.6 Increase 26.4 23.8 21.6 16.3

Footnotes

  1. The change is the companies' relative position in this list, compared to their relative position in the prior year; i.e, an increase would be moving closer to rank 1 and vice-versa

Graphical representation

Graphical representation of the top-25 Biotechnology companies sorted by market capitalisation for Q2 of 2017

See also

References


This article is issued from Wikipedia. The text is licensed under Creative Commons - Attribution - Sharealike. Additional terms may apply for the media files.